Gritstone bio, Inc. (NASDAQ:GRTS – Get Rating) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 4,400,000 shares, a growth of 11.4% from the May 15th total of 3,950,000 shares. Based on an average daily volume of 645,200 shares, the […]
Gritstone bio, Inc. (NASDAQ:GRTS – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 4,400,000 shares, an increase of 11.4% from the May 15th total of 3,950,000 shares. Approximately 5.8% of the shares of the company are short […]
Gritstone bio, Inc. (NASDAQ:GRTS – Get Rating) was the target of a significant increase in short interest in May. As of May 31st, there was short interest totalling 4,400,000 shares, an increase of 11.4% from the May 15th total of 3,950,000 shares. Based on an average daily trading volume, of 645,200 shares, the days-to-cover ratio […]
Gritstone bio, Inc. (NASDAQ:GRTS – Get Rating) insider Vassiliki Economides bought 12,000 shares of the firm’s stock in a transaction on Tuesday, May 23rd. The shares were bought at an average cost of $1.90 per share, with a total value of $22,800.00. Following the transaction, the insider now directly owns 214,058 shares of the company’s […]
Gritstone bio, Inc. (NASDAQ:GRTS – Get Rating) insider Vassiliki Economides acquired 12,000 shares of Gritstone bio stock in a transaction dated Tuesday, May 23rd. The shares were purchased at an average price of $1.90 per share, with a total value of $22,800.00. Following the acquisition, the insider now owns 214,058 shares of the company’s stock, […]